S. M. Mohamed

A recombinant antibody fragment directed to the thymic stromal lymphopoietin receptor (CRLF2) efficiently targets pediatric Philadelphia chromosome-like acute lymphoblastic leukemia.

S. Savvides, R. Lock, K. Verstraete, 2021, International journal of biological macromolecules.

An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia.

S. M. Mohamed, H. McCalmont, Peter Schofield, 2023, International journal of biological macromolecules.